Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|April 13, 2023
Short, Lipidated Dendrimeric γ-AApeptides as New Antimicrobial PeptidomimeticsYafeng Wang, Menglin Xue, Ruixuan Gao, et al.
Advanced Healthcare Materials|February 7, 2024
Antimicrobial Guanidinylate Polycarbonates Show Oral In Vivo Efficacy Against Clostridioides DifficileMenglin Xue, Soumyadeep Chakraborty, Ruixuan Gao, et al.
Infection and Immunity|August 29, 2018
Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and HamstersYuanguo Wang, Shaohui Wang, Laurent Bouillaut, et al.
Emerging Microbes & Infections|February 4, 2016
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliCChandrabali Ghose, Ioannis Eugenis, Xingmin Sun, et al.
Marine Drugs|September 22, 2022
Chemistry and Bioactivity of the Deep-Water Antarctic Octocoral <i>Alcyonium</i> spAnne-Claire D Limon, Hiran M L W Patabendige, Ala Azhari, et al.
Frontiers in Cellular and Infection Microbiology|November 4, 2024
Genomic and phenotypic characterization of a <i>Clostridioides difficile</i> strain of the epidemic ST37 type from ChinaChunhui Li, Joshua Heuler, Duolong Zhu, et al.
Environmental Microbiology|April 24, 2021
Cwl0971, a novel peptidoglycan hydrolase, plays pleiotropic roles in Clostridioides difficile R20291Duolong Zhu, Hiran Malinda Lamabadu Warnakulasuriya Patabendige, Brooke Rene Tomlinson, et al.
Infection and Immunity|May 23, 2012
A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infectionHaiying Wang, Xingmin Sun, Yongrong Zhang, et al.
Journal of the American Chemical Society|September 4, 2023
Inhibition of Hypoxia-Inducible Transcription Factor (HIF-1α) Signaling with Sulfonyl-γ-AApeptide HelicesWei Jiang, Sami Abdulkadir, Xue Zhao, et al.
ACS Central Science|May 30, 2023
An HR2-Mimicking Sulfonyl-γ-AApeptide Is a Potent Pan-coronavirus Fusion Inhibitor with Strong Blood-Brain Barrier Permeability, Long Half-Life, and Promising Oral BioavailabilitySongyi Xue, Wei Xu, Lei Wang, et al.
Pageof 8